Canopy Growth Corporation

Notably, the move did not affect the vastly larger market for recreational products. It also created new headaches for medical cannabis purveyors.

fool.com - 2026-07-17 05:30:00

For investors looking to make more green, marijuana stocks may be the way to go. Contrary to the doubt or fear based on the past, the cannabis industry is growing at a fast pace. Now, with cannabis classified as a Class 3 substance, there is very little barrier for legal operators. What that means is now there can be more product research and testing.

marijuanastocks.com - 2026-07-15 11:21:32

The latest trading day saw Canopy Growth Corporation (CGC) settling at $0.96, representing a -1.15% change from its previous close.

zacks.com - 2026-07-13 19:01:07

Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.

zacks.com - 2026-07-09 10:01:09

Canopy Growth's turnaround is real, but it remains unfinished. Profitability remains the biggest hurdle for the cannabis producer.

fool.com - 2026-07-08 11:45:00

The latest trading day saw Canopy Growth Corporation (CGC) settling at $0.95, representing a -1.04% change from its previous close.

zacks.com - 2026-07-07 19:01:07

A reverse stock split may be necessary for Canopy Growth to keep its stock price above $1 and be in compliance with Nasdaq listing requirements. Canopy Growth last did a reverse split in December 2023.

fool.com - 2026-07-07 15:35:34

As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even during the moments when many used pot stocks to get quick profits, given how the sector once began. At one point, a great deal of hype and speculation fueled investors in taking up positions for particular cannabis stocks.

marijuanastocks.com - 2026-07-06 12:42:01

While the analyst backs his bull case with estimates and facts, it's hard to envision triple-digit percentage gains for this Canada-based cannabis stock. Even if you're bullish on the U.S. legalization trend, it's smarter to stick with marijuana stocks that have stronger fundamentals.

fool.com - 2026-07-04 17:42:00

Canopy Growth Corporation (CGC) closed at $0.95 in the latest trading session, marking a -4.45% move from the prior day.

zacks.com - 2026-06-30 19:02:03

While cannabis investors finally have an expedited DEA administrative hearing on the calendar and a fresh Schedule III pathway in motion, Wall Street has stood at this exact intersection before.

247wallst.com - 2026-06-30 10:45:50

Canopy Growth is a large Canadian marijuana company. It lost money in fiscal 2026, and it isn't exactly hitting on all cylinders.

fool.com - 2026-06-28 09:15:00

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

zacks.com - 2026-06-25 10:01:14

The Canadian cannabis sector continues to evolve in 2026. Several leading companies are improving profitability while expanding international operations. At the same time, investors remain focused on revenue growth, cash flow, and market share gains. As legalization efforts continue globally, Canadian operators remain positioned to benefit from new opportunities.

marijuanastocks.com - 2026-06-23 10:00:51

Canopy Growth Corporation (CGC) concluded the recent trading session at $0.96, signifying a -1.04% move from its prior day's close.

zacks.com - 2026-06-22 19:02:05

A lot is going on in the cannabis industry between the USA and Canadian markets. As more people and companies prepare for the road ahead with the rescheduling of cannabis. This has put a lot of pressure on legal operators to make the necessary adjustments to remain compliant. However, this also impacts marijuana stock investors both in the short and long term.

marijuanastocks.com - 2026-06-17 13:26:45

Canopy Growth Corporation operates across recreational, medical, and cannabinoid-based cannabis markets. I previously rated CGC a Hold, noting that potential cannabis rescheduling benefits seemed priced in. Despite optimism, CGC's subsequent performance validated a more cautious or even bearish stance.

seekingalpha.com - 2026-06-16 09:28:44

Canopy Growth says its fiscal 2026 reset, MTL integration and medical cannabis growth can drive margin gains and positive adjusted EBITDA in fiscal 2027.

zacks.com - 2026-06-16 08:21:14

Canopy Growth is a much riskier stock than it was five years ago.

fool.com - 2026-06-16 05:45:00

Canopy Growth Corporation (WEED:CA) Q4 2026 Earnings Call Transcript

seekingalpha.com - 2026-06-15 13:12:16

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) reported a narrower quarterly loss and double-digit full-year revenue growth on Monday, as the Canadian cannabis company cited the acquisition of MTL Cannabis and a strategic recapitalization as key drivers of its turnaround effort. The company posted an adjusted loss per share of $0.29 for its fiscal fourth quarter, missing analyst estimates, though the result represented a 71% improvement from the $1.01 loss in the same period a year earlier.

proactiveinvestors.com - 2026-06-15 11:34:59

Canopy Growth NASDAQ: CGC reported higher fiscal fourth-quarter revenue and said it entered fiscal 2027 with a stronger balance sheet following a year of restructuring, cost cuts and the acquisition of MTL Cannabis.

marketbeat.com - 2026-06-15 11:04:52

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.94 per share a year ago.

zacks.com - 2026-06-15 09:21:05

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) reported a narrower quarterly loss and double-digit full-year revenue growth on Monday, as the Canadian...

proactiveinvestors.com - 2026-06-15 07:33:00

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced its financial results for the three months ended March 31, 2026 ("Q4 FY2026") and the fiscal year ended March 31, 2026 ("FY2026"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. “In fiscal 2026, we reset the business, laid a disciplined foundation, and made deliberate investments, including ac.

businesswire.com - 2026-06-15 07:00:00

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced that Claybourne's Frosted Flyers Variety Pack ha

gurufocus.com - 2026-06-08 08:00:00

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Announces Claybourne's Frosted Flyers Wins ‘Best Infused Pre-Roll' at 2026 Grow Up Awards.

businesswire.com - 2026-06-08 07:30:00

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

zacks.com - 2026-06-04 10:01:12

Canopy Growth diluted existing shareholders to pull off a recent acquisition. It is now the top medical cannabis company by revenue in Canada.

fool.com - 2026-06-03 18:00:00

Those who have been investing in marijuana stocks over the years have seen many changes. If you have been investing and trading since just before the pandemic, then you know how exciting the sector can be. With all the changes in the cannabis industry, from regulations to federal legislation, hopes are high for investors. At the start, some were filled with doubt about legal cannabis, let alone investing in marijuana stocks.

marijuanastocks.com - 2026-06-03 11:35:17

The latest trading day saw Canopy Growth Corporation (CGC) settling at $1.06, representing a -1.85% change from its previous close.

zacks.com - 2026-06-02 18:50:11

Several key metrics point to improving fundamentals.

fool.com - 2026-06-02 12:00:00

Medical marijuana was moved to the DEA's Schedule III from Schedule I. This confers some accounting advantages, at best, and the company can't even capitalize on them yet.

fool.com - 2026-06-02 01:15:00

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced the relaunch of the Tweed brand in the German me

gurufocus.com - 2026-05-29 07:00:00

SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced the relaunch of the Tweed brand in the German medical market, alongside the introduction of three cannabis strains developed by MTL Cannabis Corp. (“MTL”), a wholly-owned subsidiary of the Company. The dual milestone represents the Company's first international product release following its recent acquisition of MTL. The Tweed brand relaunch – now powered.

businesswire.com - 2026-05-29 07:00:00

The Canadian cannabis sector continues showing signs of long-term potential heading into June 2026. Several companies are expanding globally while improving operational efficiency. In addition, many cannabis investors are watching for future developments in the United States' reform. Those possible reforms could create new growth opportunities across the industry. However, volatility remains high in cannabis stocks. Because of this, traders should continue using technical analysis and proper risk management strategies. Strong balance sheets and improving revenue trends are becoming increasingly important for investors. Furthermore, companies with diversified operations may perform better during uncertain market conditions. Three Canadian cannabis companies continue attracting investor attention this month. These companies include TLRY, CGC, and VFF.

marijuanastocks.com - 2026-05-28 10:00:59

In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.07, marking a +1.9% move from the previous day.

zacks.com - 2026-05-27 18:51:06

Canopy Growth is an important player in the marijuana sector. The stock is trading in penny-stock territory.

fool.com - 2026-05-22 23:15:00

Canopy Growth gains attention as marijuana reclassification boosts cannabis sentiment, but margin pressure and execution risks persist.

zacks.com - 2026-05-22 09:21:08

The company has struggled to improve its business -- and especially to earn a profit. It also has a habit of making dilutive secondary share issues.

fool.com - 2026-05-21 05:30:00

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

zacks.com - 2026-05-20 10:01:21

Canopy Growth Corporation (CGC) closed the most recent trading day at $0.98, moving 5.55% from the previous trading session.

zacks.com - 2026-05-18 18:51:06

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) expects to release its financial results for the quarter and fiscal year ended March 31, 2026 before financial markets open on June 15, 2026. The Company also announced it plans to file restated financial results for the fiscal years ended March 31, 2025 and March 31, 2024 and to certain of the interim periods therein (the “Refiling”), in conjunction with its filing of.

businesswire.com - 2026-05-15 17:00:00

Canadian cannabis stocks remain active in May 2026. Investors continue watching the sector for growth opportunities and reform catalysts. In addition, many traders expect future federal progress in the United States. That possibility has increased interest across the entire cannabis market. Recent headlines surrounding possible cannabis rescheduling also boosted momentum in leading names.

marijuanastocks.com - 2026-05-14 10:00:31

Investors are no longer buying a hypergrowth cannabis stock. They're betting on a turnaround story.

fool.com - 2026-05-14 06:15:00

Canopy Growth Corporation (CGC) closed at $1.1 in the latest trading session, marking a -1.79% move from the prior day.

zacks.com - 2026-05-12 18:51:06

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) and Spectrum Therapeutics today announced an expansion of its Minor Cannabinoid softgel lineup, introducing new 30 and 90-pack formats and additional dosing options across its Optimized Spectrum portfolio. The expansion builds on the strong performance of existing 30-pack formats and reflects Canopy Growth's ongoing commitment to improving patient access through targete.

businesswire.com - 2026-05-07 07:30:00

Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.

zacks.com - 2026-05-05 10:01:23

Canopy Growth Corporation (CGC) reached $1.11 at the closing of the latest trading day, reflecting a +1.83% change compared to its last close.

zacks.com - 2026-04-30 18:51:08

Sin stocks attract investors for inelastic demand, steady cash flows, dividends and pricing power, often at lower valuations when excluded by ESG rules.

zacks.com - 2026-04-30 13:20:48